Sudeep Pharma IPO Price: ₹563 to ₹593 per share
IPO Dates: 21st November 2025 – 25th November 2025
Company Overview
Incorporated in 1989, Sudeep Pharma Limited is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. The company serves customers across 100+ countries.
Operations & Capacity
Sudeep Pharma operates six manufacturing facilities with a combined production capacity of 50,000 MT. The company specializes in producing key minerals such as calcium, iron, magnesium, zinc, potassium, and sodium.
Product Range
The company offers over 200 products across multiple segments, including:
- Pharmaceutical, Food & Nutrition Business
- Specialty Ingredients Business
- Triturates
Research & Development
With well-equipped in-house labs and pilot-scale facilities, the company maintains strong R&D capabilities focused on mineral salts and excipients.
Human Resources
As of December 31, 2024, Sudeep Pharma had 704 permanent employees.
Competitive Strengths
- Market leadership with a diversified portfolio in a high-barrier industry
- Strong global customer base with long-term relationships
- Regulatory-compliant, advanced manufacturing facilities
- Robust research and development capabilities.
Bidding Starts In
Sudeep Pharma IPO Specifics:
| IPO Date | November 21, 2025 to November 25, 2025 |
| Face Value | ₹1 per share |
| Price Band | ₹563 to ₹593 per share |
| Lot Size | 25 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 1,50,92,750 shares (aggregating up to ₹895.00 Cr) |
| Fresh Issue | 16,02,024 shares (aggregating up to ₹95.00 Cr) |
| Offer for Sale | 1,34,90,726 shares of ₹1 (aggregating up to ₹800.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 11,13,46,602 shares |
| Share Holding Post Issue | 11,29,48,626 shares |
Sudeep Pharma IPO Timetable (Important Dates)
| IPO Open Date | Fri, Nov 21, 2025 |
| IPO Close Date | Tue, Nov 25, 2025 |
| Tentative Allotment | Wed, Nov 26, 2025 |
| Initiation of Refunds | Thu, Nov 27, 2025 |
| Credit of Shares to Demat | Thu, Nov 27, 2025 |
| Listing Date | Fri, Nov 28, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Nov 25, 2025 |
Sudeep Pharma IPO Lot Size
Bidders have the opportunity to bid for a minimum of 25 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 25 | ₹14,825 |
| Retail (Max) | 13 | 325 | ₹1,92,725 |
| S-HNI (Min) | 14 | 350 | ₹2,07,550 |
| S-HNI (Max) | 67 | 1,625 | ₹9,93,275 |
| B-HNI (Min) | 68 | 1,700 | ₹10,08,100 |
Sudeep Pharma IPO Reservation
| QIB Shares Offered | Not more than 50 % of the Net Offer |
| Retail Shares Offered | Not less than 35%of the Net Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
Sudeep Pharma IPO Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Total Income | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| EBITDA | 48.57 | 199.28 | 187.76 | 98.64 |
| NET Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserves and Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowing | 135.97 | 135.25 | 75.03 | 82.26 |
Key Performance Indicator – Sudeep Pharma IPO
| KPI | Values |
|---|---|
| Debt/Equity | 0.20 |
| RoNW | 27.88% |
| PAT Margin | 27.63% |
| RoNW | 39.70% |
| EBITDA Margin | 14.87% |
| EBITDA Margin | 31.40% |
| Price to Book Value | 12.93 |
| Market Capitalization | ₹6,697.85 Cr. |
| EPS (Rs) | 12.46 |
| P/E (x) | 47.61 |
Prospectus Links:
Prospectus: Official documents that provide detailed information about the IPO and the company.
News Desk
